Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers

File Type:
PDFItem Type:
Journal ArticleDate:
2014Access:
openAccessCitation:
Umerska A, Paluch KJ, Santos-Martinez MJ, Corrigan OI, Medina C, Tajber L, Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers, Journal of Biomedical Nanotechnology, 10, 12, 2014, 3658 - 3673Download Item:
Abstract:
This work investigates a new type of polyelectrolyte complex nanocarrier composed of hyaluronic acid (HA) and protamine (PROT). Small (approximately 60 nm) and negatively charged nanoparticles (NPs) with a polydispersity index of less than 0.2 were obtained with properties that were dependent on the mixing ratio, concentration of polyelectrolytes and molecular weight of HA. Salmon calcitonin (sCT) was efficiently (up to 100%) associated with the NPs, and the drug loading (9.6-39% w/w) was notably high, possibly due to an interaction between HA and sCT. The NPs released -70-80% of the sCT after 24 hours, with the estimated total amount of released sCT depending on the amount of HA and PROT present in the NPs. The isoelectric point of the NPs was close to pH 2, and the negative surface charge was maintained above this pH. The HA/PROT nanoplexes protected the sCT from enzymatic degradation and showed low toxicity to intestinal epithelial cells, and thus may be a promising oral delivery system for peptides.
Sponsor
Grant Number
Science Foundation Ireland (SFI)
07/SRC/B1158
Science Foundation Ireland (SFI)
07/SRC/B1154
Higher Education Authority (HEA)
Author's Homepage:
http://people.tcd.ie/ltajberhttp://people.tcd.ie/ocorrign
http://people.tcd.ie/santosmm
http://people.tcd.ie/martinc2
Description:
PUBLISHEDSponsor:
Science Foundation Ireland (SFI)Science Foundation Ireland (SFI)
Higher Education Authority (HEA)
Type of material:
Journal ArticleSeries/Report no:
Journal of Biomedical Nanotechnology10
12
Availability:
Full text availableSubject (TCD):
Immunology, Inflammation & Infection , Nanoscience & Materials , Biomedical applications of nanotechnology , DRUG DELIVERY SYSTEMS , Nanotechnology , PharmacyDOI:
http://dx.doi.org/10.1166/jbn.2014.1878Metadata
Show full item recordThe following license files are associated with this item: